EUVIMEDEUVIMED entdecken
Crossref

IFIH1 loss of function predisposes to inflammatory and SARS‐CoV ‐2‐related infectious diseases

Rania Najm, Lemis Yavuz, Ruchi Jain, Maha El Naofal, Sathishkumar Ramaswamy, Walid Abuhammour, Tom Loney iD, Norbert Nowotny, Alawi Alsheikh-Ali, Ahmad Abou Tayoun iD, Richard K Kandasamy iD

Scandinavian Journal of Immunology · 2024

DOI: 10.1111/sji.13373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Rania Najm und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Interferon-Induced Helicase, IFIH1, COVID-19, SARS-CoV-2, Genetic Predisposition to Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Al Jalila Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The IFIH1 gene, encoding melanoma differentiation‐associated protein 5 (MDA5), is an indispensable innate immune regulator involved in the early detection of viral infections. Previous studies described MDA5 dysregulation in weakened immunological responses, and increased susceptibility to microbial infections and autoimmune disorders. Monoallelic gain‐of‐function of the IFIH1 gene has been associated with multisystem disorders, namely Aicardi–Goutieres and Singleton–Merten syndromes, while biallelic loss causes immunodeficiency. In this study, nine patients suffering from recurrent infections, inflammatory diseases, severe COVID‐19 or multisystem inflammatory syndrome in children (MIS‐C) were identified with putative loss‐of‐function IFIH1 variants by whole‐exome sequencing. All patients revealed signs of lymphopaenia and an increase in inflammatory markers, including CRP, amyloid A, ferritin and IL‐6. One patient with a pathogenic homozygous variant c.2807+1G>A was the most severe case showing immunodeficiency and glomerulonephritis. The c.1641+1G>C variant was identified in the heterozygous state in patients suffering from periodic fever, COVID‐19 or MIS‐C, while the c.2016delA variant was identified in two patients with inflammatory bowel disease or MIS‐C. There was a significant association between IFIH1 monoallelic loss of function and susceptibility to infections in males. Expression analysis showed that PBMCs of one patient with a c.2016delA variant had a significant decrease in ISG15 , IFNA and IFNG transcript levels, compared to normal PBMCs, upon stimulation with Poly(I:C), suggesting that MDA5 receptor truncation disrupts the immune response. Our findings accentuate the implication of rare monogenic IFIH1 loss‐of‐function variants in altering the immune response, and severely predisposing patients to inflammatory and infectious diseases, including SARS‐CoV‐2‐related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-Induced Helicase, IFIH1COVID-19SARS-CoV-2Genetic Predisposition to DiseaseHumansMaleFemaleChildExome SequencingLoss of Function MutationSystemic Inflammatory Response SyndromeChild, PreschoolAdolescentAdultInflammation

Stichwörter der Autor:innen

diseasesimmunodeficiencyinfectioninflammationprocesses

Substanzen

Interferon-Induced Helicase, IFIH1IFIH1 protein, human

Autor:innen und Institutionen

  • College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
  • Al Jalila Children's Hospital, Dubai, United Arab Emirates.
  • Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai Health, Dubai, United Arab Emirates.
  • Institute of Virology, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Dubai Health, Dubai, United Arab Emirates.
  • Departments of Laboratory Medicine and Pathology and Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Tom Loney, Ahmad Abou Tayoun, Richard K Kandasamy

Förderung

  • Al Jalila Foundation

Zitieren

APA

Najm, R., Yavuz, L., Jain, R., El Naofal, M., Ramaswamy, S., Abuhammour, W., Loney, T., Nowotny, N., Alsheikh-Ali, A., Abou Tayoun, A., & Kandasamy, R. K. (2024). IFIH1 loss of function predisposes to inflammatory and SARS‐CoV ‐2‐related infectious diseases. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13373

Vancouver

Najm R, Yavuz L, Jain R, El Naofal M, Ramaswamy S, Abuhammour W, et al. IFIH1 loss of function predisposes to inflammatory and SARS‐CoV ‐2‐related infectious diseases. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13373

BibTeX
@article{Najm2024,
  author = {Najm, Rania and Yavuz, Lemis and Jain, Ruchi and El Naofal, Maha and Ramaswamy, Sathishkumar and Abuhammour, Walid and Loney, Tom and Nowotny, Norbert and Alsheikh-Ali, Alawi and Abou Tayoun, Ahmad and Kandasamy, Richard K},
  title = {IFIH1 loss of function predisposes to inflammatory and SARS‐CoV ‐2‐related infectious diseases},
  journal = {Scandinavian Journal of Immunology},
  year = {2024},
  doi = {10.1111/sji.13373}
}
Kostenlos starten →